Alpa Laboratories Share PriceAlpa Laboratories

₹73.00
0.75 (1.04%)
As on 21 September, 2023 | 14:51 BSE: 532878 NSE: ALPAISIN: INE385I01010

Alpa Laboratories Performance

Day Range

  • Low 71.85
  • High 74.9
73.00

52 Week Range

  • Low 49
  • High 85.9
73.00
  • Open Price71.85
  • Previous Close72.25
  • Volume52831

Start SIP in Alpa Laboratories

Start SIP

Alpa Laboratories Share Price

  • Over 1 Month 5.19%
  • Over 3 Month 14.15%
  • Over 6 Month 39.05%
  • Over 1 Year 13.35%

Alpa Laboratories Key Statistics

P/E Ratio 11.8
PEG Ratio 0.5
Market Cap Cr 154
Price to Book Ratio 1.1
EPS 6
Dividend 0
Relative Strength Index 41.79
Money Flow Index 44.37
MACD Signal 0.8
Average True Range 3.51

Alpa Laboratories Investment Rating

  • Master Rating:
  • Alpa Laboratories has an operating revenue of Rs. 95.45 Cr. on a trailing 12-month basis. An annual revenue de-growth of -17% needs improvement, Pre-tax margin of 17% is great, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 11% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart and is trading around -2% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 94 which is a GREAT score indicating consistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 78 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Alpa Laboratories Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 252927142226
Operating Expenses Qtr Cr 272025192127
Operating Profit Qtr Cr -193-61-1
Depreciation Qtr Cr 010000
Interest Qtr Cr 000000
Tax Qtr Cr 030005
Net Profit Qtr Cr 35503-4
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 102123
Operating Expenses Annual Cr 85102
Operating Profit Annual in Cr 811
Depreciation Cr 12
Interest Annual Cr 00
Tax Annual Cr 35
Net Profit Annual Cr 1314
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 2
Cash from Investing Activity Annual Cr -17
Cash from Financing Annual Activity Cr 5
Net Cash Flow Annual Cr -10
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 145132
Fixed Assets Annual Cr 189
Total Non Current Assets Annual Cr 2727
Total Current Assets Annual Cr 151138
Total Assets Annual Cr 178165
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 6963
ROE Annual % 911
ROCE Annual % 1115
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1919
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 252927142225
Operating Expenses Qtr Cr 272025192124
Operating Profit Qtr Cr -193-611
Depreciation Qtr Cr 010000
Interest Qtr Cr 000000
Tax Qtr Cr 030005
Net Profit Qtr Cr 35503-3
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 102123
Operating Expenses Annual Cr 85102
Operating Profit Annual in Cr 811
Depreciation Cr 12
Interest Annual Cr 00
Tax Annual Cr 35
Net Profit Annual Cr 1314
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 2
Cash from Investing Activity Annual Cr -16
Cash from Financing Annual Activity Cr 5
Net Cash Flow Annual Cr -8
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 135122
Fixed Assets Annual Cr 79
Total Non Current Assets Annual Cr 1516
Total Current Assets Annual Cr 152139
Total Assets Annual Cr 167155
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 6458
ROE Annual % 912
ROCE Annual % 1216
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1919

Alpa Laboratories Technicals

EMA & SMA

Current Price
₹73.00
0.75 (1.04%)
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • ₹75.53
  • 50 Day
  • ₹73.65
  • 100 Day
  • ₹70.2
  • 200 Day
  • ₹66.87
  • 20 Day
  • ₹76.86
  • 50 Day
  • ₹74.08
  • 100 Day
  • ₹68.65
  • 200 Day
  • ₹64.65

Alpa Laboratories Resistance and Support

PIVOT
₹72.62
Resistance
First Resistance ₹73.44
Second Resistance ₹74.62
Third Resistance ₹75.44
RSI 41.79
MFI 44.37
MACD Single Line 0.8
MACD -0.08
Support
First Resistance ₹71.44
Second Resistance ₹70.62
Third Resistance ₹69.44

Alpa Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 45,647 2,721,931 59.63
Week 58,795 3,612,968 61.45
1 Month 222,871 10,922,912 49.01
6 Month 125,545 6,737,991 53.67

Alpa Laboratories Result Highlights

Alpa Laboratories Synopsis

NSE-Medical-Generic Drugs

Alpa Laboratories Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 92.44 Cr. and Equity Capital is Rs. 21.04 Cr. for the Year ended 31/03/2023. Alpa Laboratories Ltd. is a Public Limited Listed company incorporated on 18/03/1988 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L85195MP1988PLC004446 and registration number is 004446.
Market Cap 154
Sales 95
Shares in Float 0.90
No of funds 1
Yield
Book Value 1.05
U/D Vol ratio 2
LTDebt / Equity 2
Alpha 0.09
Beta 0.68

Alpa Laboratories

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 57.29%57.29%57.29%57.29%
Foreign Portfolio Investors 0.14%
Financial Institutions/ Banks 0.01%0.01%
Individual Investors 37.79%38.1%37.88%37.72%
Others 4.91%4.6%4.83%4.85%

Alpa Laboratories Management

Name Designation
Mr. Mahendra Singh Chawla Chairman
Mr. Paresh Chawla Managing Director
Mr. Devendra Baheti Independent Director
Mr. Sharad Chand Lunawat Independent Director
Mr. Krishna Das Malani Independent Director
Mrs. Jyoti Jain Independent Director
Mr. Pravin Shah Director

Alpa Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Alpa Laboratories Corporate Action

Date Purpose Remarks
2023-08-14 Quarterly Results
2023-05-29 Audited Results
2023-02-14 Quarterly Results
2022-11-14 Quarterly Results
2022-08-13 Quarterly Results
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Alpa Laboratories FAQs

What is Share Price of Alpa Laboratories ?

Alpa Laboratories share price is ₹73 As on 21 September, 2023 | 14:37

What is the Market Cap of Alpa Laboratories ?

The Market Cap of Alpa Laboratories is ₹153.6 Cr As on 21 September, 2023 | 14:37

What is the P/E ratio of Alpa Laboratories ?

The P/E ratio of Alpa Laboratories is 11.8 As on 21 September, 2023 | 14:37

What is the PB ratio of Alpa Laboratories ?

The PB ratio of Alpa Laboratories is 1.1 As on 21 September, 2023 | 14:37

Q2FY23